Loading stock data…
INBS
$2.41-0.04 (-1.63%)
Market ClosedLast close May 1
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Intelligent Bio Solutions Inc. in the Healthcare sector is trading at $2.41. The stock is currently near its 52-week low of $2.29, remaining 73.7% below its 200-day moving average. Technical signals show neutral RSI of 48 and bullish MACD crossover, explaining why INBS maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 48) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.41
Potential Upside
5%
Whystock Fair Value$2.53
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelli...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.82M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
4.59
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-101.81%
Volume
Today's trading volume
65,334
Recent News
Top Midday Decliners
Intelligent Bio Solutions (INBS) reported late Wednesday an agreement with two healthcare-focused in
BC-Most Active Stocks
td class="col-issue">New Era Energy & Digital Inc.
Intelligent Bio Solutions Full Year 2025 Earnings: US$2.00 loss per share (vs US$6.38 loss in FY 2024)
NasdaqCM:INBS 1 Year Share Price vs Fair Value Explore Intelligent Bio Solutions's Fair Values from the Community and...
EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4
Intelligent Bio Solutions Inc. (NASDAQ:INBS) reported preliminary fiscal fourth quarter revenue results and selected operational highlights on Thursday. Intelligent Bio Solutions is a medical technology company delivering intelligent, rapid, noninvasive testing solutions. “Fiscal 2025 represented a year of disciplined execution and strategic investment. For the fiscal fourth quarter, we expect to report another quarter of sequential and year-over-year revenue growth,” said Harry Simeonidis, Pres
EXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level
Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced the collection of new data that further reinforces the security and performance of its Intelligent Fingerprinting Drug Screening System, strengthening its FDA 510(k) submission. "We are planning to submit our findings to the FDA in August, along with the new data collected," said Peter Passaris, Vice President of Product Development. The company completed cybersecurity testing, including penetration testing and electromagnetic c